SEC Filing Summary: Amedica Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Amedica Corporation on June 26, 2015, reporting events as of June 25, 2015. The filing details the status of a secondary offering completed on November 26, 2014, and subsequent warrant exercises.
Key Financial Metrics and Capital Structure
- Secondary Offering: Completed November 26, 2014, involving the sale of 11,441,646 units at $1.14 per unit.
- Warrant Issuance: Total of 13,157,892 Secondary Offering Warrants issued (including 1,716,246 from over-allotment).
- Warrant Exercises: As of the report date, 13,015,912 warrants were exercised via cashless provision, resulting in the issuance of 38,147,958 shares of common stock.
- Outstanding Warrants: 141,980 Secondary Offering Warrants remain outstanding.
- Shares Outstanding: 65,758,131 shares of common stock as of the report date.
Note: The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change reported is the significant increase in outstanding common stock due to the cashless exercise of the majority of warrants issued in the November 2014 secondary offering. The filing does not provide comparative financial data to assess changes in revenue or profitability versus prior periods.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the disclosure of the capital structure changes. No unusual items or contingencies are described in this specific report.
Investor Verification Checklist
- Verify the impact of the 38,147,958 newly issued shares on existing shareholder dilution.
- Confirm the current market price of the stock relative to the $1.14 offering price to assess the value of the remaining 141,980 warrants.
- Review the company's most recent 10-K or 10-Q for financial performance metrics (revenue, cash flow) not included in this 8-K.
- Check for any subsequent filings regarding the exercise of the remaining outstanding warrants.